177Lu-DOTA-M-5-A

N/A

Report date: 2025/11/05 17:48:42

Base Information

Drug Name177Lu-DOTA-M-5-A

Drug Alias Name177Lu-DOTA-M5A177Lu-DOTA-M-5-A

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionAnti-CEA

TargetsCarcinoembryonic antigen

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUppsala University

China Registration ClassN/A

Develop Information

Active CompaniesUppsala University

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A